CTRI/2023/01/049229已完成不适用
Evaluation of irritation potential of Skin care formulations on healthy human subjects having varied skin type.
Kama Ayurveda Pvt Ltd1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2023年1月31日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 26
- 试验地点
- 1
- 主要终点
- Dermatological safety / Irritation potential on skin
研究概览
简要总结
Objective: The objective of this study is to evaluate the irritation potential on healthy human subjects having varied skin types of Skin Care Formulations.
Duration of study: 8 days study
Kinetics: T0 (Evaluation of test sites by Dermatologist, Patch application) ,T1(Patch removal, Evaluation of test sites by Dermatologist ,T2(Evaluation of test sites by Dermatologist and Subject post 24 hrs of patch removal), T8 (Evaluation of test sites by Dermat and Subject post 1 week of patch removal and tracking the positive cases)
Population: 26 healthy subjects (13 males + 13 females) with varied skin types.
The test area is checked for erythema and oedema caused due to the products and compared with positive control
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Healthy Human Subjects 2) Skin should be healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….).
- •Subjects willing to come for regular follow up and ready to follow instructions during the study period.
- •Subjects representing varied skin types (ideally equal representation of all 4 skin types – Oily, Normal, Dry and Combination).
排除标准
- •1 For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2 Having refused to give his/her assent by not signing the consent form 3 Taking part in another study liable to interfere with this study 4 Being diabetic. 5 Being asthmatic. 6 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 7 Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin). 8 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 9 Having undergone a surgery requiring a general anaesthesia of more than one hour in the past 6 months. 10 Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit. 11 The day of the patch application: no cosmetic product must be used (test site clean with water only). Refusing to follow the restrictions below during the study:.
- •For female: Do not become pregnant nor breastfeed.
- •Do not take part in another study liable to interfere with this study.
- •Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, and antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
- •Do not change his/her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit 12 Having eczema, psoriasis, lichen plan, vitiligo whatever the considered area 13 Having disorder of the healing (whatever the considered area) • Having a rhinitis, allergic conjunctivitis, or rhino sinusitis 14 Having an allergy to perfumes and/or conservatives in cosmetic products 15 Having an allergy to plaster 16 Having a food allergy 17 Having a cardiovascular pathology (taking a beta blocker treatment) 18 Having immunosuppressive drugs, such as cyclophosphamide, methotrexate, azathioprine, etc. 19 Taking a retinoid-based treatment by general or oral route 20 Taking specific treatment on the back. 21 Having taken an anti-histaminic treatment in the last 2 weeks preceding the start of the study 22 Having miliaria (prickly heat) on the back. 23 Presenting too many naevus on the back 24 Having high pilosity on the back. 25 Refusing to follow the restrictions below during the study:.
- •During the first 24 hours (after patch application), neither cosmetic products nor water must be applied on the back.
- •Till the follow up period of until T8 days, only water is accepted from the first reading i.e., T2 days (24 hours after the patch removal).
- •Do not practice an intensive sport activity during the first 24 hours (until the removal of the patches).
- •Do not expose the back to the sun.
结局指标
主要结局
Dermatological safety / Irritation potential on skin
时间窗: Baseline,0 hrs,24 hrs and 7 days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Study to check safety of products on human volunteersCTRI/2025/02/081224Geenia International Pvt Ltd26
尚未招募
不适用
Assessment of safety of skinCTRI/2021/02/031097Mountain Valley Springs India Pvt Ltd24
已完成
不适用
Safety evaluation of Skin care formulationsCTRI/2023/05/053027Mosaic wellness pvt ltd26
尚未招募
不适用
Study to check if cosmetic products are safe to use on people.CTRI/2025/06/089357Evove Skincare Pvt Ltd.26
尚未招募
不适用
Study to check the safety of cosmetic products on healthy human subjectsCTRI/2025/05/087679Ajanta Pharma Ltd.26